Detalhe da pesquisa
1.
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine.
Ann Intern Med
; 174(5): 585-594, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587687
2.
Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age.
Hum Vaccin Immunother
; 18(5): 2044255, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344464
3.
Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa.
Malar J
; 10: 224, 2011 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21816029
4.
Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults.
Hum Vaccin Immunother
; 17(5): 1366-1373, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33175637
5.
Two decades of commitment to malaria vaccine development: GlaxoSmithKline Biologicals.
Am J Trop Med Hyg
; 77(6 Suppl): 289-95, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18165505
6.
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
PLoS One
; 4(7): e6465, 2009 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-19649245
7.
Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial.
Trials
; 8: 11, 2007 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-17386091